These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16230083)

  • 1. Nod2 in normal and abnormal intestinal immune function.
    Abreu MT
    Gastroenterology; 2005 Oct; 129(4):1302-4. PubMed ID: 16230083
    [No Abstract]   [Full Text] [Related]  

  • 2. Getting to the guts of NOD2.
    Kelsall B
    Nat Med; 2005 Apr; 11(4):383-4. PubMed ID: 15812518
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation.
    Kramer M; Netea MG; de Jong DJ; Kullberg BJ; Adema GJ
    J Leukoc Biol; 2006 Apr; 79(4):860-6. PubMed ID: 16461743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CARD15/NOD2 mutations in Crohn's disease.
    Hugot JP
    Ann N Y Acad Sci; 2006 Aug; 1072():9-18. PubMed ID: 17057186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop.
    Begue B; Dumant C; Bambou JC; Beaulieu JF; Chamaillard M; Hugot JP; Goulet O; Schmitz J; Philpott DJ; Cerf-Bensussan N; Ruemmele FM
    J Cell Physiol; 2006 Nov; 209(2):241-52. PubMed ID: 16897777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.
    van Heel DA; Hunt KA; Ghosh S; Hervé M; Playford RJ
    Eur J Immunol; 2006 Jun; 36(6):1629-35. PubMed ID: 16637007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can NOD2/CARD15 mutations predict intestinal graft-versus-host disease and aid our understanding of Crohn's disease?
    Rogler G; Holler E
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):62-3. PubMed ID: 16265048
    [No Abstract]   [Full Text] [Related]  

  • 8. NOD2 in Crohn's disease--loss or gain of function mutations?
    Zelinkova Z; Stokkers P; Hommes DW
    Neth J Med; 2005 Sep; 63(8):286-7. PubMed ID: 16186636
    [No Abstract]   [Full Text] [Related]  

  • 9. Human genetics. Tackling common disease.
    Todd JA
    Nature; 2001 May; 411(6837):537, 539. PubMed ID: 11385552
    [No Abstract]   [Full Text] [Related]  

  • 10. NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link?
    Grimm MC; Pavli P
    Gut; 2004 Nov; 53(11):1558-60. PubMed ID: 15479670
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired innate immunity in Crohn's disease.
    Comalada M; Peppelenbosch MP
    Trends Mol Med; 2006 Sep; 12(9):397-9. PubMed ID: 16890491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crohn's gene identified.
    Frankish H
    Lancet; 2001 May; 357(9269):1678. PubMed ID: 11425381
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammatory diseases: is ubiquitinated NEMO at the hub?
    Burns KA; Martinon F
    Curr Biol; 2004 Dec; 14(24):R1040-2. PubMed ID: 15620634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nod toward understanding Crohn's disease.
    Secko D
    CMAJ; 2005 Mar; 172(6):738-9. PubMed ID: 15767604
    [No Abstract]   [Full Text] [Related]  

  • 15. NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease.
    Watanabe T; Kitani A; Strober W
    Gut; 2005 Nov; 54(11):1515-8. PubMed ID: 16227353
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype.
    Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
    Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CARD15/NOD2 mutations are not related to abdominal PFAPA.
    Maschio M; Oretti C; Ventura G; Pontillo A; Tommasini A
    J Pediatr; 2006 Sep; 149(3):427. PubMed ID: 16939769
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
    D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
    Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New targets for Crohn's disease.
    Pestell K
    Trends Pharmacol Sci; 2001 Jul; 22(7):342. PubMed ID: 11431024
    [No Abstract]   [Full Text] [Related]  

  • 20. Mapping the effects of genetic susceptibility and Mycobacterium avium subsp. paratuberculosis infection on Crohn's disease: strong but independent.
    Sieswerda LE; Bannatyne RM
    J Clin Microbiol; 2006 Mar; 44(3):1204-5. PubMed ID: 16517933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.